Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
CRIZOTINIB VERSUS PEMETREXED OR DOCETAXEL CHEMOTHERAPY IN ADVANCED, ALK-POSITIVE NON-SMALL CELL LUNG CANCER: A RANDOMIZED PHASE III STUDY (PROFILE 1007)
- Authors
- Kim, DW[Kim, Dong-wan]; Janne, PA[Janne, Pasi A.]; Nakagawa, K[Nakagawa, Kazuhiko]; Seto, T[Seto, Takashi]; Crino, I[Crino, I.]; Ahn, MJ[Ahn, Myung-ju]; De Pas, TM[De Pas, T. M.]; Besse, B[Besse, Benjamin]; Solomon, B[Solomon, Ben]; Blackball, F[Blackball, Fiona]; Wu, YL[Wu, Yi-long]; Thomas, M[Thomas, Michael]; O'Byrne, KJ[O'Byrne, Kenneth J.]; Moro-Sibilot, D[Moro-Sibilot, Denis]; Camidge, DR[Camidge, D. R.]; Hirsh, V[Hirsh, Vera]; Mok, TSK[Mok, Tony S. K.]; Tassell, V[Tassell, Vanessa]; Polli, A[Polli, A.]; Shaw, AT[Shaw, A. T.]
- Issue Date
- Nov-2012
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- crizotinib; phase III; ALK; LUNG CANCER
- Citation
- JOURNAL OF THORACIC ONCOLOGY, v.7, no.11, pp.S445 - S446
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF THORACIC ONCOLOGY
- Volume
- 7
- Number
- 11
- Start Page
- S445
- End Page
- S446
- ISSN
- 1556-0864
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.